DC
Defender Capital Portfolio holdings
AUM
$295M
This Quarter Return
-6.09%
1 Year Return
+53.43%
3 Year Return
+101.94%
5 Year Return
+160.32%
10 Year Return
–
AUM
$288M
AUM Growth
+$288M
(-7.8%)
Cap. Flow
-$791K
Cap. Flow
% of AUM
-0.28%
Top 10 Holdings %
Top 10 Hldgs %
87.34%
Holding
45
New
2
Increased
13
Reduced
9
Closed
9
Top Buys
| 1 |
STAAR Surgical
STAA
|
$9.62M |
| 2 |
Teledyne Technologies
TDY
|
$7.58M |
| 3 |
Vanguard Short-Term Treasury ETF
VGSH
|
$3.47M |
| 4 |
Bloom Energy
BE
|
$3.13M |
| 5 |
Axon Enterprise
AXON
|
$589K |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
$8.44M |
| 2 |
Costco
COST
|
$7.15M |
| 3 |
Monster Beverage
MNST
|
$6.58M |
| 4 |
Danaher
DHR
|
$1.76M |
| 5 |
Pfizer
PFE
|
$764K |
Sector Composition
| 1 | Healthcare | 34.21% |
| 2 | Technology | 18.68% |
| 3 | Financials | 14.24% |
| 4 | Consumer Staples | 9.06% |
| 5 | Industrials | 6.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vanguard Short-Term Treasury ETF
VGSH
$22.9B
| $45.8M | 15.91% |
772,246
+58,550
| +8% | +$3.47M |
|
|
2
Danaher
DHR
$147B
| $42.4M | 14.74% |
143,752
-5,980
| -4% | -$1.76M |
|
|
3
Berkshire Hathaway Class B
BRK.B
$1.09T
| $40.5M | 14.07% |
115,711
-24,151
| -17% | -$8.44M |
|
|
4
STAAR Surgical
STAA
$1.36B
| $31.1M | 10.8% |
387,857
+120,065
| +45% | +$9.62M |
|
5
Fortive
FTV
$16.2B
| $28.4M | 9.89% |
460,616
+9,325
| +2% | +$576K |
|
|
6
Axon Enterprise
AXON
$58.7B
| $15M | 5.22% |
107,810
+4,230
| +4% | +$589K |
|
|
7
Teledyne Technologies
TDY
$25.2B
| $13.4M | 4.66% |
28,480
+16,129
| +131% | +$7.58M |
|
|
8
Costco
COST
$418B
| $13.4M | 4.64% |
23,195
-12,423
| -35% | -$7.15M |
|
|
9
Monster Beverage
MNST
$60.9B
| $12.4M | 4.31% |
153,019
-81,310
| -35% | -$6.58M |
|
10
Enovis
ENOV
$1.77B
| $8.9M | 3.1% |
220,616
+5,275
| +2% | +$213K |
|
11
Lineage Cell Therapeutics
LCTX
$267M
| $7.98M | 2.78% |
5,006,185
+8,315
| +0.2% | +$13.3K |
|
12
Intel
INTC
$107B
| $7.72M | 2.68% |
154,565
+900
| +0.6% | +$44.9K |
|
|
IMDX
13
Insight Molecular Diagnostics Inc. Common Stock
IMDX
$72.4M
| $4M | 1.39% |
2,562,130
+345,330
| +16% | +$539K |
|
|
14
Bloom Energy
BE
$12.4B
| $3.6M | 1.25% |
151,000
+131,000
| +655% | +$3.13M |
|
15
Palantir
PLTR
$372B
| $2.17M | 0.75% |
153,065
+30,755
| +25% | +$436K |
|
16
Lifecore Biomedical
LFCR
$285M
| $1.39M | 0.48% |
121,450
-5,000
| -4% | -$57.1K |
|
17
Apple
AAPL
$3.45T
| $1.14M | 0.4% |
6,503
-1,511
| -19% | -$264K |
|
18
Amazon
AMZN
$2.44T
| $808K | 0.28% |
248
| – | – |
|
19
Kinder Morgan
KMI
$60B
| $775K | 0.27% |
41,000
| – | – |
|
20
ANI Pharmaceuticals
ANIP
$2.03B
| $675K | 0.23% |
24,000
+5,000
| +26% | +$141K |
|
21
Compugen
CGEN
$132M
| $674K | 0.23% |
209,272
-2,250
| -1% | -$7.25K |
|
22
American Well
AMWL
$111M
| $669K | 0.23% |
141,525
-8,700
| -6% | -$41.1K |
|
23
Microsoft
MSFT
$3.77T
| $643K | 0.22% |
2,085
+20
| +1% | +$6.17K |
|
24
Mirion Technologies
MIR
$4.73B
| $628K | 0.22% |
60,000
| – | – |
|
25
iShares Core S&P 500 ETF
IVV
$662B
| $535K | 0.19% |
1,179
| – | – |
|